Understanding the Patient Experience in Progesterone Management for Endometrial Cancer and Complex Atypical Hyperplasia
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 21-010212
Sponsor Protocol Number: 21-010212
About this study
The purpose of this study is to gain a deeper understanding of the specific patient experience for women undergoing progesterone management for early-stage endometrial cancer and complex atypical hyperplasia due to morbid obesity (BMI ≥ 40).
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Biopsy confirmed Grade 1-2 endometrioid endometrial cancer or complex atypical hyperplasia.
- No major surgery within 3 months of diagnosis.
- Diagnosis in the last 10 years.
- BMI ≥ 40 kg/m^2.
- English speaking.
Exclusion Criteria:
- Non-English speaking.
- Advanced stage endometrial cancer or histology other than endometrioid.
Eligibility last updated 5/13/22. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Carrie Langstraat, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available